Literature DB >> 9087954

Alterations in the expression of ELAM-1, ICAM-1 and VCAM-1 after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus.

S Shahgasempour1, S B Woodroffe, H M Garnett.   

Abstract

Human cytomegalovirus (HCMV) infection of endothelial cells resulted in increased adhesion of the cells to peripheral blood leukocytes. It was demonstrated by flow cytometry that increased adhesiveness parallels the increased expression of cell surface adhesion molecules (ELAM-1, ICAM-1, VCAM-1). The increased adhesion of PMN and T-lymphocytes was due to upregulation in the expression of ELAM-1 and ICAM-1. The upregulation of VCAM-1 resulted in the increased adhesiveness of monocytes and T-lymphocytes to HCMV-infected HUVEC. The increased adhesiveness to leukocytes was caused by HCMV replication since endothelial cells exposed to HCMV-free supernatants and UV-inactivated HCMV did not show any increase in adhesiveness to any of the leukocytes tested.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9087954     DOI: 10.1111/j.1348-0421.1997.tb01177.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  14 in total

1.  Increased expression of LDL receptor-related protein 1 during human cytomegalovirus infection reduces virion cholesterol and infectivity.

Authors:  Nicole Gudleski-O'Regan; Todd M Greco; Ileana M Cristea; Thomas Shenk
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

Review 2.  Microbes, inflammation and atherosclerosis: will old pathology lessons guide new therapies?

Authors:  G M Vercellotti
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

3.  NAD(P)H oxidase and eNOS play differential roles in cytomegalovirus infection-induced microvascular dysfunction.

Authors:  Igor L Leskov; Jennifer Whitsett; Jeannette Vasquez-Vivar; Karen Y Stokes
Journal:  Free Radic Biol Med       Date:  2011-10-06       Impact factor: 7.376

4.  Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV.

Authors:  Gretchen L Bentz; Marta Jarquin-Pardo; Gary Chan; M Shane Smith; Christian Sinzger; Andrew D Yurochko
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

5.  P-selectin mediates the microvascular dysfunction associated with persistent cytomegalovirus infection in normocholesterolemic and hypercholesterolemic mice.

Authors:  Evgeny Senchenkov; Mikhail V Khoretonenko; Igor L Leskov; Dmitry V Ostanin; Karen Y Stokes
Journal:  Microcirculation       Date:  2011-08       Impact factor: 2.628

Review 6.  Acceleration of allograft failure by cytomegalovirus.

Authors:  Daniel N Streblow; Susan L Orloff; Jay A Nelson
Journal:  Curr Opin Immunol       Date:  2007-08-22       Impact factor: 7.486

7.  Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage.

Authors:  Gary Chan; Elizabeth R Bivins-Smith; M Shane Smith; Patrick M Smith; Andrew D Yurochko
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 8.  Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing.

Authors:  D N Streblow; J Dumortier; A V Moses; S L Orloff; J A Nelson
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

9.  Enhanced cytomegalovirus infection in atherosclerotic human blood vessels.

Authors:  Pamela L Nerheim; Jeffery L Meier; Mohammad A Vasef; Wei-Gen Li; Ling Hu; James B Rice; Daniel Gavrila; Wayne E Richenbacher; Neal L Weintraub
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

10.  Control of Rta expression critically determines transcription of viral and cellular genes following gammaherpesvirus infection.

Authors:  James R Hair; Paul A Lyons; Kenneth G C Smith; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.